Literature DB >> 20463569

Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis.

Shriram Jakate1, Annoel Yabes, Deborah Giusto, Bita Naini, Charles Lassman, Matthew M Yeh, Linda D Ferrell.   

Abstract

A rare variant of hepatocellular carcinoma (HCC) is encountered that produces small cirrhosis-like nodules diffusely throughout the liver (CL-HCC), instead of a larger evident mass. This pattern remains undetected as carcinoma clinically and radiographically and is unexpectedly discovered after liver transplantation in the explanted native liver. We studied 10 such cases (9 males and 1 female, age 35 to 80 y) from 4 medical centers. The pretransplant clinical, laboratory, and radiographical studies were reviewed to determine the cause and stage of liver disease, alpha-fetoprotein (AFP) levels, and detectability of a mass on imaging. All 10 cases had underlying cirrhosis of varying etiology [3 hepatitis C virus (HCV), 3 alcoholic hepatitis, 1 hepatitis B virus, 1 autoimmune, and 2 mixed HCV/alcoholic hepatitis and hemochromatosis/HCV] and underwent orthotopic liver transplantation with no preoperative clinical suspicion of HCC. Ultrasound and/or dynamic imaging showed cirrhosis and no definite HCC. AFP levels were only mildly elevated in only 3 of 10 cases (144, 150, and 252 ng/mL). Grossly, there were innumerable (from about 20 to >1000) small CL-HCC nodules (0.2 to 0.6 cm) scattered among cirrhotic nodules. Histologically, these were well or moderately differentiated HCC, often with pseudoglandular pattern, perinodular sclerotic rims, cholestasis, frequent Mallory bodies, and small vessel invasion. In addition to the usual HCC immunophenotype, CL-HCC showed frequent ubiquitin and cytoplasmic and membranous CD10 positivity, relatively low Ki-67 proliferative index and absence of AFP immunohistochemically. CL-HCC warrants recognition as a unique HCC variant that evades pretransplant detection despite massive tumor burden, mimics cirrhotic nodules, and shows some uncommon pathologic and immunophenotypical characteristics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463569     DOI: 10.1097/PAS.0b013e3181ddf52f

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

Review 1.  Tissue diagnosis of hepatocellular carcinoma.

Authors:  Deepali Jain
Journal:  J Clin Exp Hepatol       Date:  2014-04-01

2.  Liver transplantation and cirrhotomimetic hepatocellular carcinoma: classification and outcomes.

Authors:  Erica F Clayton; Saloni Malik; Alexander Bonnel; Yifei Mu; Kim Olthoff; Abraham Shaked; Peter L Abt; Heather Peterman; K Rajender Reddy; Shane Ottmann; Emma E Furth; Matthew H Levine
Journal:  Liver Transpl       Date:  2014-05-26       Impact factor: 5.799

3.  Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification.

Authors:  Kun Jiang; Sameer Al-Diffhala; Barbara A Centeno
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

4.  Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature.

Authors:  Anıl Çolaklar; Namık Kemal Altınbaş
Journal:  J Ultrason       Date:  2020-03-31

Review 5.  Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.

Authors:  Jelena Djokic Kovač; Aleksandra Janković; Aleksandra Đikić-Rom; Nikica Grubor; Andrija Antić; Vladimir Dugalić
Journal:  Curr Oncol       Date:  2022-01-30       Impact factor: 3.677

6.  Educational Case: Evaluating a patient with cirrhosis.

Authors:  Tyler J Reed; Danielle D'Ambrosio; Barbara E C Knollmann-Ritschel
Journal:  Acad Pathol       Date:  2022-07-01

7.  Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.

Authors:  Ihab Shafek Atta
Journal:  Histol Histopathol       Date:  2021-07-13       Impact factor: 2.303

8.  Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.

Authors:  Ricardo C Gehrau; Kellie J Archer; Valeria R Mas; Daniel G Maluf
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

9.  Clinical Features and Clonal Origin of Diffuse Hepatocellular Carcinoma.

Authors:  Zheng-Lu Wang; Lu-Zhou Zhang; Yu-Liang Wang; Wei-Ping Zheng; Hong Zheng
Journal:  Chin Med J (Engl)       Date:  2018-05-05       Impact factor: 2.628

Review 10.  Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Jelena Djokic Kovac; Tamara Milovanovic; Vladimir Dugalic; Igor Dumic
Journal:  World J Gastroenterol       Date:  2020-05-07       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.